Lv1
70 积分 2024-06-17 加入
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
4小时前
待确认
Epidemiology of nasopharyngeal carcinoma: current insights and future outlook
3天前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
9天前
已完结
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
2个月前
已完结
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
2个月前
已完结
Diagnosis and Management of Multiple Myeloma
2个月前
已完结
[Guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)]
3个月前
已完结
Consideration of stratification in confirmatory trials with time-to-event endpoint
4个月前
已完结
皖公网安备34019202002308
